Manzer H, Nobbs A, Doran K
Front Microbiol. 2020; 11:602305.
PMID: 33329493
PMC: 7732690.
DOI: 10.3389/fmicb.2020.602305.
Matsumoto-Nakano M
Jpn Dent Sci Rev. 2018; 54(1):22-29.
PMID: 29628998
PMC: 5884221.
DOI: 10.1016/j.jdsr.2017.08.002.
Kressirer C, Smith D, King W, Dobeck J, Starr J, Tanner A
J Oral Biosci. 2017; 59(3):135-141.
PMID: 29104444
PMC: 5665406.
DOI: 10.1016/j.job.2017.05.002.
Heim K, Sullan R, Crowley P, El-Kirat-Chatel S, Beaussart A, Tang W
J Biol Chem. 2015; 290(14):9002-19.
PMID: 25666624
PMC: 4423689.
DOI: 10.1074/jbc.M114.626663.
Heim K, Crowley P, Long J, Kailasan S, McKenna R, Jeannine Brady L
Proc Natl Acad Sci U S A. 2014; 111(44):15746-51.
PMID: 25331888
PMC: 4226092.
DOI: 10.1073/pnas.1413018111.
Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.
Robinette R, Heim K, Oli M, Crowley P, McArthur W, Jeannine Brady L
Vaccine. 2013; 32(3):375-82.
PMID: 24252705
PMC: 3901311.
DOI: 10.1016/j.vaccine.2013.11.023.
Lab-Test(®) 4: Dental caries and bacteriological analysis.
Cura F, Palmieri A, Girardi A, Martinelli M, Scapoli L, Carinci F
Dent Res J (Isfahan). 2013; 9(Suppl 2):S139-41.
PMID: 23814571
PMC: 3692161.
DOI: 10.4103/1735-3327.109723.
A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.
Robinette R, Oli M, McArthur W, Jeannine Brady L
Vaccine. 2011; 29(37):6292-300.
PMID: 21704107
PMC: 3156276.
DOI: 10.1016/j.vaccine.2011.06.027.
Crystal structure of the C-terminal region of Streptococcus mutans antigen I/II and characterization of salivary agglutinin adherence domains.
Larson M, Rajashankar K, Crowley P, Kelly C, Mitchell T, Jeannine Brady L
J Biol Chem. 2011; 286(24):21657-66.
PMID: 21505225
PMC: 3122222.
DOI: 10.1074/jbc.M111.231100.
Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine.
Salam M, Katz J, Michalek S
Vaccine. 2010; 28(31):4928-36.
PMID: 20653102
PMC: 2910446.
DOI: 10.1016/j.vaccine.2010.05.039.
Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.
Tavares M, Silva B, Cavalcante R, Souza R, Luiz W, Paccez J
FEMS Immunol Med Microbiol. 2010; 59(2):131-42.
PMID: 20402772
PMC: 4369793.
DOI: 10.1111/j.1574-695X.2010.00669.x.
Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.
Robinette R, Oli M, McArthur W, Jeannine Brady L
J Immunol. 2009; 183(7):4628-38.
PMID: 19752237
PMC: 2810654.
DOI: 10.4049/jimmunol.0803300.
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach.
Kuepper M, Huhn M, Spiegel H, Ma J, Barth S, Fischer R
BMC Biotechnol. 2005; 5:4.
PMID: 15667665
PMC: 548521.
DOI: 10.1186/1472-6750-5-4.
Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components.
Hamada T, Kawashima M, Watanabe H, Tagami J, Senpuku H
Infect Immun. 2004; 72(8):4819-26.
PMID: 15271944
PMC: 470681.
DOI: 10.1128/IAI.72.8.4819-4826.2004.
Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain.
Seifert T, Bleiweis A, Jeannine Brady L
Infect Immun. 2004; 72(8):4699-706.
PMID: 15271931
PMC: 470626.
DOI: 10.1128/IAI.72.8.4699-4706.2004.
Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.
Rhodin N, Cutalo J, Tomer K, McArthur W, Jeannine Brady L
Infect Immun. 2004; 72(8):4680-8.
PMID: 15271929
PMC: 470667.
DOI: 10.1128/IAI.72.8.4680-4688.2004.
Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity.
Tsuha Y, Hanada N, Asano T, Abei T, Yamaguchi S, Salam M
Clin Exp Immunol. 2004; 137(2):393-401.
PMID: 15270858
PMC: 1809101.
DOI: 10.1111/j.1365-2249.2004.02548.x.
The rational design of an anti-caries peptide against Streptococcus mutans.
Younson J, Kelly C
Mol Divers. 2004; 8(2):121-6.
PMID: 15209163
DOI: 10.1023/b:modi.0000025655.93643.fa.
Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.
Rhodin N, Van Tilburg M, Oli M, McArthur W, Jeannine Brady L
Infect Immun. 2003; 72(1):13-21.
PMID: 14688075
PMC: 343944.
DOI: 10.1128/IAI.72.1.13-21.2004.
Characterization of the conformational epitope of Guy's 13, a monoclonal antibody that prevents Streptococcus mutans colonization in humans.
van Dolleweerd C, Chargelegue D, Ma J
Infect Immun. 2003; 71(2):754-65.
PMID: 12540555
PMC: 145350.
DOI: 10.1128/IAI.71.2.754-765.2003.
